TACROLIMUS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Tacrolimus Market, By Product Type (Tacrolimus Capsules and Tablets, Tacrolimus Ointment, Tacrolimus Injection, and Tacrolimus Granules), By Application (Immunosuppression, Dermatitis, and Others), By End User (Organ Transplant Centers, Hospitals, Clinics, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In: 16 Feb, 2026
Code: CMI2298
Page number: 151
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026 - 2033

Tacrolimus is a calcineurin inhibitor and potent immunosuppressive drug that is primarily used to prevent cellular rejection following organ transplantation. It is also used topically to treat severe atopic dermatitis, severe refractory uveitis following bone marrow transplants, and the skin disorder vitiligo. Tacrolimus is available in capsule, granules for oral suspension (to be combined with liquid), extended-release (long acting) capsule, and extended-release tablet for oral administration. Tacrolimus immediate-release formulations, in combination with other immunosuppressants, are approved for the prevention of organ rejection in adult and pediatric patients receiving allogeneic liver, kidney, heart, or lung transplants. Tacrolimus extended-release formulations are approved for the prevention of organ rejection in adult and pediatric patients having kidney transplants when combined with other immunosuppressants, and may be used in patients who have been converted from immediate-release formulations.

Market Dynamics

The increasing product launch by the key players in the market is expected to drive the market growth over the forecast period. For instance, in June 2020, Sandoz, a Novartis division and a global leader in generic pharmaceuticals and biosimilars, announced the launch of once-daily generic tacrolimus capsules known as Dailiport in Germany, the U.K., The Netherlands, Finland, Sweden, Estonia, Latvia, and Slovakia, and as Conferoport in Italy and Spain.

Moreover, key companies in the market are focusing on inorganic growth strategies such as distribution of tacrolimus products, which is expected to drive the market growth over the forecast period. For instance, in January 2022, Mayne Pharma Group Limited, an Australia-based specialty pharmaceutical company announced that it had begun distribution of tacrolimus ointment, 0.1% in the U.S. Tacrolimus ointment is a generic version of PROTOPIC, indicated for the treatment of Atopic dermatitis.

Key features of the study

This report provides an in-depth analysis of the global tacrolimus market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global tacrolimus market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Novartis AG, Mylan N.V., Astellas Pharma Inc., Dr. Reddy's Laboratories Ltd., Pfizer Inc., Abbott, Senju Pharmaceutical Co. Ltd., Glenmark Pharmaceuticals Ltd., Lupin Limited, and Vibcare Pharma Pvt. Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global tacrolimus market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts1
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tacrolimus market

Market Segmentation

By Product Type
- Tacrolimus Capsules and Tablets
- Tacrolimus Ointment
- Tacrolimus Injection
- Tacrolimus Granules
By Application
- Immunosuppression
- Dermatitis
- Others
By End User
- Organ Transplant Centers
- Hospitals
- Clinics
- Others
By Regional Insights
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC Countries
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - North Africa
  - Central Africa
Key Players Insights
- Novartis AG
- Mylan N.V.
- Astellas Pharma Inc.
- Reddy's Laboratories Ltd.
- Pfizer Inc.
- Abbott
- Senju Pharmaceutical Co. Ltd.
- Glenmark Pharmaceuticals Ltd.
- Lupin Limited
- Vibcare Pharma Pvt. Ltd.

Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

Market Purview

Report Description

Market Definition and Scope

Executive Summary

Market Snippet, By Product Type
Market Snippet, By Application
Market Snippet, By End User
Market Snippet, By Region

Coherent Opportunity Map (COM)

Market Dynamics, Regulations, and Trends Analysis

Market Dynamics

Drivers
Restraints
PEST Analysis
PORTER’s Five Forces Analysis
Market Opportunities
Regulatory Scenario
Key Developments
Industry Trend

Global Tacrolimus Market, By Product Type, 2026-2033, (USD Bn)

Introduction

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Tacrolimus Capsules and Tablets

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends

Tacrolimus Ointment

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends

Tacrolimus Injection

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Tacrolimus Granules

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Global Tacrolimus Market, By Application, 2026-2033, (USD Bn)

Introduction

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Immunosuppression

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends

Dermatitis

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends

Others

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends

Global Tacrolimus Market, By End User, 2026-2033, (USD Bn)

Introduction

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends

Organ Transplant Centers

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends

Hospitals

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends

Clinics

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends

Others

Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends

Global Tacrolimus Market, By Region, 2026-2033, (USD Bn)

Introduction

Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, For Region, 2021 - 2033

North America

Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)

U.S.
Canada

Latin America

Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)

Brazil
Argentina
Mexico
Rest of Latin America

Europe

Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)

U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe

Asia Pacific

Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific

Middle East

Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)

GCC Countries
Israel
Rest of Middle East

Africa

Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)

South Africa
North Africa
Central Africa

Competitive Landscape

Heat Map Analysis
Market Share Analysis (3x3 Matrix)
Company Profiles

Novartis AG

Company Overview
Product Type Portfolio
Recent Developments/Updates

Mylan N.V.

Company Overview
Product Type Portfolio
Recent Developments/Updates

Astellas Pharma Inc.

Company Overview
Product Type Portfolio
Recent Developments/Updates

Dr. Reddy's Laboratories Ltd.

Company Overview
Product Type Portfolio
Recent Developments/Updates

Pfizer Inc.

Company Overview
Product Type Portfolio
Recent Developments/Updates

Abbott

Company Overview
Product Type Portfolio
Recent Developments/Updates

Senju Pharmaceutical Co. Ltd.

Company Overview
Product Type Portfolio
Recent Developments/Updates

Glenmark Pharmaceuticals Ltd.

Company Overview
Product Type Portfolio
Recent Developments/Updates

Lupin Limited

Company Overview
Product Type Portfolio
Recent Developments/Updates

Vibcare Pharma Pvt. Ltd.

Company Overview
Product Type Portfolio
Recent Developments/Updates

Analyst Recommendation

Wheel of Fortune
Analyst View
Coherent Opportunity Map

Section

References
Research Methodology
About Us and Sales Contact

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now